Navigation Links
World Heart Corp. Completes $7.3 Million Private Placement
Date:1/26/2010

SALT LAKE CITY, Jan. 26 /PRNewswire-FirstCall/ -- World Heart Corporation ("WorldHeart"; Nasdaq: WHRT), a developer of mechanical circulatory systems, announced today that it has completed its previously announced private placement of common stock and warrants to purchase common stock. Gross proceeds from the offering were approximately $7.3 million. Proceeds from the private placement are expected to be used for general corporate and working capital purposes.

WorldHeart issued an aggregate of 1,418,726 newly-issued shares of common stock and warrants to purchase up to 2,837,452 additional shares of common stock. WorldHeart expects to receive net proceeds of approximately $7.1 million after deducting offering expenses.

The financing was led by existing investors, Special Situations Funds, Venrock and New Leaf Venture Partners, and included several new investors. Thomas Weisel Partners LLC acted as Placement Agent on the private placement.

In connection with the financing, WorldHeart has agreed, subject to certain terms and conditions, to file a registration statement under the Securities Act covering the registration of the common stock and the shares underlying the warrants acquired at closing within 60 days after closing.

This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities.

For additional information, please refer to WorldHeart's current report on Form 8-K filed with the Securities and Exchange Commission with respect to this transaction.

About WorldHeart

WorldHeart is a developer of mechanical circulatory support systems headquartere
'/>"/>

SOURCE World Heart Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Aspirin Named 8th World Wonder by Majority of Americans
3. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
4. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
5. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
6. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
11. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013  Hologic, Inc. (Hologic or the Company) ... manufacturer and supplier of premium diagnostics, medical imaging ... serving the healthcare needs of women, today announced ... U.S. clinical practice comparing breast cancer screening with ... 2D mammography alone showed a significant reduction in ...
(Date:5/23/2013)... , May 23, 2013  Ameritox, the nation,s ... by Progressive Medical, Inc. to become part of ... clients manage pharmacy costs and improve the clinical ... a leading pharmacy benefit manager in the workers, ... medication compliance and pain management strategy for several ...
(Date:5/23/2013)... , May 23, 2013 Israel Brain ... 2013 , Israel,s 1 st ... 14 th -15 th in Tel Aviv ... innovative city in the world by the Wall Street ... BrainTech Israel 2013 will showcase the latest breakthroughs in ...
Breaking Medicine Technology:First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
(Date:5/24/2013)... Paris, France: Routinely measuring fractional flow reserve (FFR) ... diagnosis of chest pain leads to significant changes ... according to results from a study reported at ... wire assessment influence management strategy at coronary angiography ... to assess whether routine assessment of FFR in ...
(Date:5/24/2013)... at Oregon Health & Science University highlights an ingenious ... with the highly evasive HIV virus that causes AIDS. ... unique approach to develop its own HIV vaccine candidate, ... studies. This latest research finding will be published in ... Science . , "A major challenge in developing ...
(Date:5/24/2013)... May 24, 2013 CBT News.com recently announced ... joins the web-based retail automotive industry news organization with 12 ... “I’m excited to join a group that’s so forward-thinking in ... of how online video content is on the rise.” , ... motorcycle business and segued into advertising at Cycle News and ...
(Date:5/24/2013)... York, NY (PRWEB) May 24, 2013 ... Antigua (AICASA) has signed an articulation agreement with ... their students to study abroad in Antigua. ... three college credits after participating in a cell biology ... an articulation agreement with American University of Antigua ...
(Date:5/24/2013)... half of recommended well-child visits had up to twice ... most of their visits, according to a study published ... . The study included more than 20,000 children enrolled ... conditions like asthma and heart disease were even more ... to the study. In fact, children with chronic ...
Breaking Medicine News(10 mins):Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2Health News:AICASA Signs Articulation Agreement with Old Dominion University to Create Study Abroad Program 2Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3
... singled out tumor specific alterations in cellular pathway ... is administered to patients suffering from multiple myeloma.researchers have ... that might improve chances of patients responding ... to frame tailor treatment to patients with multiple myeloma, ...
... an Indian American scientist, has held out a hope ... several diseases including cancer, HIV/AIDS and malaria. // ... would work against several diseases like cancer malaria and ... and Drug Administration (FDA) and are studying how to ...
... outbreaks of the deadly Ebola virus in Africa have been ... //Hotly debated has been whether these wild ape deaths were ... published in the journal Science puts this debate to rest, ... at a single site. The study also provides new hope ...
... NSW has grown two-fold, according to a recent study. // ... on the increase and presently 50% of the adult and 25% ... ,In 1997 the incidence of diabetics in NSW was 4.3% ... 6.9 and 8.4% until last year. 90% o which belonged to ...
... to a study finding of Ron Matsusaki, a doctor from ... of 14,000 //residents on the western tip of Canada's Prince ... in patients who live near a toxic waste site. ... pesticides 80 percent of which is used for potato farming ...
... the latest findings of the researchers at Mayo Clinic, Minnesota ... developing// enlarged prostates up to 50%.’ The results of this ... ,Benign prostatic hyperplasia, a condition that could make urination ... the doctors. More than half of the men in their ...
Cached Medicine News:Health News:Tailor-made Cancer Treatment for Multiple Myeloma Patients Offered by Mayo Clinic 2Health News:Indian American Scientist at Work on Multi-targeted Drug 2Health News:Ebola-Outbreak Kills 5000 Gorillas 2Health News:Ebola-Outbreak Kills 5000 Gorillas 3
... is designed to play a key ... research involves proteomics, cytomics or genomics. ... enhanced firmware, powerful Optima eXPert software ... L-XP delivers superior functionality, optimized user ...
... integrated chemistry system brings versatility in ... smaller laboratory. A model of innovation ... chemistry system features state-of-the-art Dimension testing ... environment, in a flexible. affordable, easy-to-use ...
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
... convenience make the RD/Hitachi 902 the ... workload laboratory. Compact, sample selective clinical ... 26 tests on board (including 3 ... tests per hour respectively up to ...
Medicine Products: